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ABSTRACT
Objective: This study investigates clinicians’ views of
health-related wearable technologies in the context of
supporting osteoarthritis (OA) long-term management.
Clinicians’ preferences are critical in identifying realistic
implementation strategies for such technologies.
Design: Qualitative study incorporating an inductive
thematic analysis applied to identify key themes from
clinicians’ responses.
Participants: Clinicians, including 4 general
practitioners, 4 physiotherapists and 5 orthopaedic
surgeons were interviewed.
Setting: The study was conducted in a University
setting.
Results: Participants all agreed wearable technologies
could positively complement their role and enhance
their relationship with patients. Perceived benefits of
wearable technologies included monitoring patients’
progress, treatment evaluation, monitoring compliance
and informing clinical decision-making. The device
should be designed to provide objective data of
patients’ locomotion capability in an easy and timely
fashion via a simple interface. Data should be available
to both clinicians and patients to provide them with the
motivation to achieve clinical goals and allow them to
take ownership of their treatment. The use of
technology was also seen as a way to more effectively
plan treatment and manage patients’ contact time
saving time and cost.
Conclusions: Findings support the use of wearable
technologies to enhance current OA management and
suggest clinical uses. Adoption of technologies could
have implications on the effectiveness of treatment
provided overcoming current barriers, in particular
compliance with treatment.
INTRODUCTION
Osteoarthritis (OA), among other musculo-
skeletal conditions, is one of the most
common causes of long-term adult disability.1
Eighty per cent of those affected report
some degree of functional limitation and
25% cannot perform major daily living activ-
ities.2 The prevalence of OA is set to rise
along with its economic burden both from
direct and indirect associated costs, which
are already high.3 4
A paradigm shift in the management of
long-term conditions, such as OA, towards
self-management strategies has been advo-
cated to reduce the patient and societal
burden of such diseases.4 5 For OA, guide-
lines recommend rehabilitation based on
exercise programmes to mitigate symptoms
and disease progression. However, the effect-
iveness of these protocols is highly depend-
ent on supervision and compliance, which is
often poor.6 Recent advancements in
health-related measuring technologies could
offer new opportunities for delivery of
rehabilitation programmes outside a clinical
setting, allowing remote monitoring and
feedback of key measures to both health pro-
fessionals and patients.7 8 These portable
devices could potentially enable patients to
become more active in the management of
their condition and fulﬁl their interest in
personalised health information while also
aligning with the current focus on patient
self-management7 as well as the need for
more accurate objective measures of patients’
functions.9
These devices are designed to record
quantitative data in a mobile environment,
embedded in the user’s clothing or ﬁtted as
Strengths and limitations of this study
▪ This is the first study to evaluate the use of
wearable technologies from a clinical perspective
in the context of osteoarthritis care.
▪ In-depth interviews allowed an understanding of
clinicians’ preferences to identify adoption strat-
egies of wearable technologies within an osteo-
arthritis rehabilitation framework.
▪ Osteoarthritis requires different categories of
health professionals involved in its management
and these were interviewed in this study.
▪ Results are based on a small sample size of clin-
icians recruited within the London National
Health Service (NHS) area.
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an accessory.10 Numerous devices have been developed
to date aimed at monitoring patient ambulatory per-
formance for rehabilitation purposes, but their uptake
and acceptance in clinical environments remains
poor.11–13 The uptake of these technologies is inﬂu-
enced by their intended use, perceived usefulness, ease
of learning, success in early experimentation, right ﬁt to
a speciﬁc clinical context as well as user needs.13–15
Therein lies a problem. The development of these tech-
nologies has been largely driven by engineering require-
ments.12 Consequently, less attention has been devoted
to users’ preferences.11 12 Recent research conducted to
address this gap in knowledge has focused on examining
patients’ preferences for wearable technologies. By con-
trast, comparatively scarce attention has been given to
health professionals’ views of these devices.12 16
Therefore, we know relatively little about how these
devices might work in the context of clinical practice.
Health professionals, like patients represent a key user
group. Unlike patients, however, they possess knowledge
and insight of clinical practice, which would be critical
in identifying realistic implementation strategies.
Moreover, health professionals could assist with promot-
ing acceptability among patient groups.
Since each device should address the complexity of a
targeted condition, our initial focus has been the use of
wearable systems in the context of guiding and support-
ing OA rehabilitation. OA requires different categories
of health professionals involved in its management.4 We
asked general practitioners (GPs), physiotherapists and
orthopaedic surgeons their views of wearable technology
and how they would use it in their practice. The aim of
this study was to investigate health professionals’ per-
spective of wearable technology and draw on the ﬁnd-
ings to develop a wearable system for OA rehabilitation.
The ﬁndings from in-depth interviews are reported.
METHODS
Study design
This study was a qualitative study based on in-depth
interviews with health professionals. All participants pro-
vided written informed consent form prior to each
interview.
Participants
A total of 13 health professionals (age range 35–
74 years) were recruited for the study within the London
National Health Service (NHS) area. Health profes-
sionals were invited to take part by email invitation sent
over a year period starting from January 2014. The parti-
cipants consisted of four physiotherapists, four GPs and
ﬁve orthopaedic surgeons. All participants had at least
7 years of experience in their specialty up to 40 years of
practice. Physiotherapists were specialised in musculo-
skeletal conditions, four out of ﬁve surgeons were specia-
lised in hip and knee joint surgeries and one in spine
surgeries. GPs practised in different areas of London
covering more to less afﬂuent neighbourhoods.
Interviews
Semistructured interviews were conducted by two
researchers (EP and GMM). Interviews were tape
recorded and transcribed verbatim. Interviews lasted
between 30 and 45 min. Participants were asked a series
of open-ended questions formulated to explore their
knowledge and views of wearable technologies (box 1).
Interview questions were developed to touch issues of
technologies uses, impact on practice and ﬁt on clinical
routine with particular reference to practical issues of
what to measure and feedback. A brief introduction on
the scope of the interview and research project was pro-
vided at the beginning of the interview session.
Qualitative data analysis
The transcribed data from the interviews were analysed
using an inductive thematic analysis process17 to ensure,
Box 1 Interview open-ended questions
I. Contextual background
1. What is/can you describe your professional role?
2. What types of patients do you come into contact with?
A. Is there a particular type/category?
B. Does it vary?
C. How many patients do you see per day?
D. Is there a particular age range of patients you
work with?
3. Does most of your work involve assessing patients’
mobility?
4. What is the general remit of your work?
II. Wearable technologies
1. Do you know anything about wearable devices?
2. If so tell me what you know
3. How are they used?
4. From what you know, what’s your view of them?
5. How would such a device help you in your own work?
6. How would you use them? Or if you can think of one
use which will be the most appropriate for you?
A. Do you think such a device would be good for
patients? Would you use with all patients?
B. If this device could offer some functionality that
you think may be important what would that be?
C. Is there anything you would like to monitor in
particular?
7. How would you ideally record the data and how would
you like them to be available to you?
III. Impact of wearable technologies on current practice
8. Can you envisage a way that such a device might nega-
tively impact on your work?
9. Do you think wearable devices could replace part of the
routine process patients are treated with?
10. From your professional perspective can you describe
what you would want from such a device?
IV. Closure
11. Is there anything else that you would like to add about
wearable devices that we haven’t covered here?
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where possible, that the analysis was data driven and not
wholly driven by theoretical or analytic interest. First, EP
and GMM examined the interview data to establish pre-
liminary themes, which were extracted through careful
examination of the respondents’ accounts. Second,
these preliminary themes were reanalysed by EP and
GMM to ensure a closer alignment with participants’
responses and to establish main recurrent themes.
Finally, EP and GMM examined each other’s data set to
facilitate consistent interpretative analysis of the data
and clarify the key ﬁndings.
RESULTS
All three professional groups highlighted the potential
of using wearable technologies in OA management to
improve service and patients’ experience. All were able
to provide examples of wearable technologies either
coming from personal use or general knowledge.
Overall wearable technology was seen as a tool to
support and solidify objective measures of treatment
planning to guide and motivate patients. The analytical
process revealed four main recurrent themes: utility,
doctor–patient relationship, design speciﬁcation and
critical aspects/negative impact on practice. These
themes are described below and verbatim comments are
indicated using the following notation: P to indicate phy-
siotherapists, OS to indicate orthopaedic surgeons and
GP denotes general practitioners.
Utility
Interviewees extensively commented on how the tech-
nology could be used in clinical practice. The main uses
are summarised in box 2.
All participants agreed that the technology would not
play a major role in diagnostic assessment and rather
than replacing a clinician’s role it would support it.
Clinicians considered the devices as tools that could
provide objective measures of clinical changes as adjunct
to the subjective account from the patient of their level
of pain, movement and activity.
Surgeons have been diagnosing for a long time. The
device is not really going to help with diagnosis. (OS2)
Add on, support to what we do, I do not think you can
negate what physios do especially with OA. It will give
nice objective sense of where the patient is at..but you
cannot move away from actually having someone listen-
ing to what you are saying. (P4)
Traditional assessment tools would remain as the
mainstay for diagnosis especially for physiotherapists and
surgeons; however, GPs suggested that they could use
the data for referral decisions:
If we see someone with a knee problem we’re not going
to refer all of them on to an orthopaedic team. As a tool
for discriminating which patients should be referred or
not it could be useful. (GP3)
The provision of patient data and clinical decision-making
The provision of objective data by these devices was
recognised as a tool to help, devise treatment plans and
support clinical decision-making. Both the physiothera-
pists and surgeons held the view that a wearable device
could be a measure of clinical treatment that would be
objective and evidence based to support analytical
practice:
Objective records so that treatment could be planned
based on that and then see what happen after you
change the gait. (OS5)
It[the device] would enable us to become more analyt-
ical…Having something where we can actually say look
we’ve made a change with this intervention and here’s
the data that would be nice…we’re going to need more
scientiﬁc backup for the things we do. (P4)
The device would be able to provide an objective
measure of progress and mobility in contrast to the sub-
jective account of the patient that could be now checked
against the objective data provided by the device:
Objective data rather than subjective as the one picked
up in the clinics and of what the patient is telling you;
whereas the device will bring you more real time object-
ive data analysis and hopefully this will give you a clear
understanding and idea of how the patient is doing.
(OS3)
You have to start with their subjective data and see if that
is supported by more objective data. (GP1)
Data will allow clinicians to objectively measure
improvement which has been poorly deﬁned to date:
For us at the minute objectify what better means is quite
difﬁcult whereas having something more scientiﬁc to
analyse would make mapping their progress a little more
clinical signiﬁcant for them. (P4)
Moreover, it will allow an assessment not conﬁned to a
visit snapshot:
If someone is watching you walking you do not walk with
a normal gait, do you?…it will be an adjunction sort to
conﬁrm what your suspicious were, so as much as you
send someone for MRI you could look at that data and
say well actually in the clinic he was limping but actually
when is out and about his walking is not too bad…it
Box 2 Utility of technology in clinical practice
1. Progress monitor
2. Realistic assessment/support treatment planning
3. Motivate patients
4. Efficient management
5. Treatment evaluation
6. Monitor compliance
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giving you that sort of ﬂy in the wall sort of perspective of
the patient so that you could see what’s happening when
they are not thinking about you being there. (GP2)
In supporting clinical decision, some respondents also
described the technology as a tool that could evaluate
the effectiveness of the treatment provided. In this
context, it could be the success of a surgical intervention
or exercise programme:
…hardcore evidence of how different operations affect
patients. (OS1)
The core functionality was identiﬁed in patients moni-
toring. The beneﬁt from the monitoring is twofold: (1)
to motivate patients; (2) to improve OA management
effectiveness. In relation to the former one physiother-
apist commented:
Progress tracker will hugely improve their motivation and
would be really nice to have this record. (P1)
Managing referral and patient contact time
Improving management effectiveness was a particular
focus for GPs and physiotherapists where patients’ visits
are numerous, frequent and affected by time constraints.
Technology could assist in making the OA care process
more efﬁcient. The additional information that it brings
along can be used to book appointment more wisely when neces-
sary, maximising clinicians and patients time:
Waiting list are high whereas with something like that I
could say to them look you ring in and tell me what you
are recording…it may reduce the amount of contact
time we need with patients and they are satisﬁed because
they are achieving what they need to. (P3)
It followed to some extent that the technology was
considered as a means to accelerate recovery:
If a patient using the device have done all your exer-
cises…They may then contact and say your device you
gave me told me I am actually doing really well, can I
now progress? Rather than waiting too long and not pro-
gressing soon enough. (P4)
Compliance
Poor patient compliance to treatment course emerged
from the interviews. As already mentioned, technology
could motivate patients and along with day-by-day ‘sur-
veillance’ could impact positively on compliance to
treatment.
This device can allow monitoring, once you monitor
them you can tell they are not doing their exercise and
gear them up a bit, patients have other commitments,
other pressures so sometimes their rehabilitation doesn’t
happen so that’s a problem we need to sort out, compli-
ance is the biggest problem. (OS3)
Patients have awful compliance with exercise diaries
having something where you can’t ﬁddle and I would be
able to see what you’ve done and how many times you’ve
done it and how well… (P4)
Doctor–patient relationship
On the whole, all the professional groups were of the
view that wearable technologies monitoring the patients
would enhance rather than interfere with the doctor–
patient relationship:
The device would objectify the patient/doctor relationship
but in a positive way. The patient would feel you know more
about them…they would then know that I care more
because I know that bit more about them…and your
chances of making a mistake are reduced. (OS1)
The enhancement of this relationship can reassure
patients that they are receiving high-quality treatment:
A lot of this people are generally told you’ve got arthritis it is
a fact of life, get on with it, and so they kind of feel a bit lost
as if none actually watching them and monitoring them and
giving them any help and assistance in what they should or
should not be doing and so something like that may offer
them almost that someone is listening to me someone cares
about how I am getting on and how I am doing on a daily
basis, how my condition is progressing.. (P4)
Ownership of information
Ownership of the information from the device has to be
with the patient. The patient should be able to take owner-
ship of the information and use it to their advantage. (GP1)
Having more information to hand will give patients’ the
opportunity to be more in charge of their condition pro-
moting self-management. However, supervision will
always be ensured:
I have control and the patient has control, what you do
not want to happen is the patient to go away with the
device and overdoing something or underdoing but over-
doing create more pain. (P3)
With the use of technology both health professionals
and patients will be equally involved in their OA treat-
ment. This will allow improved organisation of the man-
agement and provision of care; planning appointments
only when necessary with the backup of objective infor-
mation in home environment:
It would allow remote assessment and so save patients
having to travel into hospital…it would be a bit like
bringing the lab out to the patient’s home. (OS3)
Design specification
In terms of appearance, all participants agreed that the
technology should be wearable, small, easy to get on and
off, robust, discrete and aesthetically preferable:
People do not like to know they are on show. (P2)
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It should not inhibit movement and be “easy to
remember to carry around” (P1). Moreover it should
be simple to operate, user-friendly and “viable for both
young and older group” (P2) while still maintaining
a level of adaptability to different people to use.
Feedback should be available to both patients and clin-
icians and it was suggested to use an app for tablets/
smartphones. The app interface should be simple with
mainly graphical visualisation of data processed, “not
much language” (GP1), “no raw data” (OS5), “brief
summary report” (GP3) and allowing “little interaction
with the user as possible” (P2). Patients’ reports should
be received by clinicians automatically “at different
time frames according to the stage and use of the
patients” (GP4) but with “alarms ﬂagging up problems”
(OS4).
From the interviews, it emerged how technology
should be speciﬁc for the condition targeted. This dic-
tates positioning,
A wearable device if it is for orthopaedic it is all about
movement so it has to be close to the joint, placed in the
lower limb. (OS3)
as well as what to measure:
Blood pressure, pulse not useful for what we are doing
here as musculoskeletal physios. (P1)
With regard to what to measure GPs emphasised they
would like “simple measures of improvement or deteri-
oration” whereas physiotherapists and surgeons would
like more speciﬁc details and quantiﬁcation of patients’
locomotion. These included distance, step length,
speed, cadence, symmetry between legs, muscle activa-
tion, joint loading, ground reaction force, range of
motion at selected joints, joint angles:
At the moment we can only infer patients metrics (e.g.
knee angles). If you don’t have enough knee ﬂexion you
cannot run that fast. OA knee is less ﬂexible we need to
know how much they are doing. (OS1)
An overall interest was also expressed in general activ-
ity level, activities performed, ‘time spent on their feet
as opposed to seating’, ‘How much they can do? How
much do they do?’, ‘number of time they perform an
exercises instructed’. It was also pointed out the import-
ance of being easily quantiﬁable information ‘where
clinicians can tap in targets’.
Critical aspects/negative impact on practice
The most prevailing limitation to adoption was identi-
ﬁed in the time required for managing the technology.
This would include time to interpret and understand
the data:
You need time to get used to it and interpreting what
you need to look for. (OS3)
And time to instruct patients on how to use the
technology:
It should be other people to handle the equipment and
use it and know how to help the patients with it because
our workload is already busy. (GP4)
Cost-effectiveness was also critical for adoption:
I am not sure how far the technology is today and also if
the cost is at a level that is affordable for the NHS. (GP4)
However, this could be overcome:
Cost may be an issue but not insurmountable, if it is
worth it you can justify it. (OS5)
Patients’ acceptance will play a role in the continuous
use of the device:
Compliance is a real issue as I wonder if patients will
actually wear these devices at home. (OS3)
To this, it adds on a counter motivational effect the
device could have on patient:
It might show up what they’re not doing rather than
what they are doing and for some that could be a
de-motivator, so choose the right people to use it with.
(P2)
Success will hence be achieved by targeting the
patients to who the device could be given:
…Select patients to give it to, I do not want to waste their
time and my time, it is the same of any intervention,
there is a bit of judgment call and deciding who you are
giving it to. (P4)
DISCUSSION
Understanding the actual context of use of wearable
technology against the background of patients’ knowl-
edge and awareness of their treatment and progress, is
critical to gathering a deeper understanding of the will-
ingness to use technology in everyday clinical practice.
Relatively few studies have examined health profes-
sionals’ acceptance of health-related wearable devices
and, to our knowledge, none have reported on their use
within the context of OA management from a clinical
user perspectives.12 14 18–21 Despite studies reporting on
the use of technology for the OA population, the major-
ity of these studies were conducted in research settings
in preclinical phases and did not report users’ prefer-
ences and how to use the information obtained in
routine clinical practice.11 22–24 The ﬁndings from our
study indicate how technology could prove beneﬁcial for
health professionals groups touching on issues of patient
management, doctor–patient interaction, compliance,
feedback and impact on practice. By investigating health
professionals’ viewpoints, this study provides novel
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insights on how technology could be integrated into
current OA care along with design recommendations to
be met by developers.
All three groups, physiotherapists, surgeons and GPs,
were in agreement that technology would not replace
their role but will offer support and enhancement to
patient care. This was also the case for conditions other
than OA.18 19 Participants agreed that technology could
add a limited value to the diagnostic process but its
value could be proved in long-term management, offer-
ing monitoring and objective measures of patients’
status, if implemented appropriately. Adoption of tech-
nology in current practice was related, in the ﬁrst
instance, to its ease of use and its effectiveness in provid-
ing easy to interpret and timely data to clinicians. These
factors were seen as critical in encouraging patient com-
pliance to use the technology. However, health profes-
sionals can play a critical role in enabling
implementation. For example, participants reported that
non-compliance with the technology could be avoided
by careful selection of patients who are more likely to
positively receive the technology and make the most of
its use. In another study conducted by some members of
this research team, it was found that patients with OA
from different age and sociodemographic groups were
enthused by the technology and highly motivated to use
it to support the management of their condition.16
Aligning these preferences with the clinicians’ prefer-
ences outlined in this study would appear to be a solid
prospect for developing adoption strategies within clin-
ical settings.
Our study highlights clinicians’ views on how these
devices could help improve compliance to treatment
and self-motivation, issues well documented in the litera-
ture.25–27 In addition, the provision of objective data
could enable goal setting and progress monitoring both
critical components of any long-term treatment pro-
gramme.27–30 It is important, however, that measures of
performance/goals are tailored and personally meaning-
ful to the patients and their conditions.14 21 28–30
Participants suggested variables they would like to
monitor in relation to OA to be able to use such tech-
nologies to map patients’ progress and inform treat-
ment. GPs suggested they would prefer simple measures
of improvements whereas both physiotherapists and sur-
geons would prefer more detailed information of loco-
motion capability. Participants recommended that the
measurable outputs from these technologies should be
easily quantiﬁable to establish speciﬁc goals relating to
locomotion performance (eg, joint loading, step length,
range of motion, sagittal angles) and not just to activity
levels. Advocated technologies should be able to
measure and monitor such variables and report on
them periodically in the form of graphical reports avail-
able to both health professionals and patients.
Remote monitoring and patient self-monitoring was
conveyed as an approach that could allow better time
management and reduce unnecessary hospital
appointments. A hint of more effective care provision
and recovery process emerged from the interviews.
Hospital visits could be planned when necessary with
the back-up of technology data, ﬂagging positive and
critical situations. A more evidence-based practice could
be developed with the technology, which allows clini-
cians to evaluate treatment options, and thus maximises
effectiveness of the interventions. The likelihood of
reducing appointments and enhancing patient function,
through an inexpensive technological approach, could
save time and cost. Joint replacements, days at work lost,
medication and comorbidities could all be reduced if
care is effectively delivered saving money to the health-
care systems and patients themselves.4
The continuous exchange of information between
patients and clinicians was envisaged to reinforce the
patient/doctor relationship while providing patients with
the opportunity for more independent management of
their own condition. This is in line with patients’ views
on how technology and more information could allow
them to take control and seek clinical support when
necessary, pacing care to their needs and convenience.16
The technology could provide that sense of supervision
and continuous guidance during treatment which is
otherwise lacking in current practice.16 A recent paper
highlighted the gap in OA management at early stages
until surgery remains the only option.31 The authors call
for new solutions to be implemented that need to be
personalised and actively involve both patients and clini-
cians. Current guidelines reﬂect this need promoting
exercise and self-management to improve patients’ func-
tion.5 Technology as a tool for self-management could
offer this opportunity if both patients and clinicians’
needs are targeted and cooperate harmoniously.
We acknowledge the limitations of these ﬁndings, that
they are based on a small-scale interviewees group from
the London NHS area. However, the group comprised
differing healthcare practitioners, all involved in the
care pathway of patients with OA, to allow a more
general viewpoint. Their views were similar and where
major distinctions were noted they have been high-
lighted. A good level of data saturation was achieved, but
in light of the small group, a broader generalisation of
the ﬁndings may require more participants from other
areas than London. Nevertheless, this paper opens up
unspoken issues that could help in the development of
new technologies-based approach for OA rehabilitation
meeting a clear clinical need in this ﬁeld and foraging
for new collaborations between technology engineers
and end-users.
In conclusion, the perceived usefulness and uptake of
wearable technology is critically inﬂuenced by its speciﬁ-
city to the targeted condition.13–15 However, effective
implementation of any technology in a given context
should feature the views of potential users. We have
investigated views on usability and acceptability of
health-related wearable devices with a small group of
health professionals in the context of OA. Overall, the
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ﬁndings support the use of technology to assist treat-
ment of patients with OA to enhance current care.
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